BioHarvest Sciences Inc. (BHST) stock
BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.50−0.13 (-7.67%)
Close on Nov 13, 2026Market cap $34.11MP/E –Yield –
BioHarvest Sciences ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was -$3.95M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.95M | – |
| FY2024 | Dec 31, 2024 | -$5.74M | – |
| FY2023 | Dec 31, 2023 | -$9.13M | – |
See a number that looks wrong?